NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,287,496 | +0.3% | 621,319 | -0.6% | 0.01% | +7.7% |
| Q2 2023 | $63,084,405 | +9.7% | 625,155 | -0.0% | 0.01% | 0.0% |
| Q1 2023 | $57,522,801 | -8.1% | 625,248 | -9.4% | 0.01% | -7.1% |
| Q4 2022 | $62,616,327 | +23.6% | 690,215 | +3.6% | 0.01% | +16.7% |
| Q3 2022 | $50,656,000 | -21.6% | 666,443 | -12.8% | 0.01% | -20.0% |
| Q2 2022 | $64,640,000 | -5.0% | 764,684 | -1.4% | 0.02% | +15.4% |
| Q1 2022 | $68,076,000 | +5.1% | 775,789 | +4.8% | 0.01% | +8.3% |
| Q4 2021 | $64,763,000 | +14.9% | 740,419 | +7.5% | 0.01% | +9.1% |
| Q3 2021 | $56,352,000 | -4.4% | 689,059 | +6.6% | 0.01% | 0.0% |
| Q2 2021 | $58,965,000 | +10.6% | 646,264 | +3.6% | 0.01% | 0.0% |
| Q1 2021 | $53,311,000 | -8.3% | 623,676 | +1.3% | 0.01% | -15.4% |
| Q4 2020 | $58,133,000 | +5.7% | 615,622 | -2.7% | 0.01% | -7.1% |
| Q3 2020 | $55,007,000 | -2.8% | 632,546 | -2.4% | 0.01% | -6.7% |
| Q2 2020 | $56,603,000 | -5.6% | 648,082 | -10.9% | 0.02% | -25.0% |
| Q1 2020 | $59,978,000 | -16.8% | 727,448 | -4.4% | 0.02% | +5.3% |
| Q4 2019 | $72,071,000 | +32.3% | 761,119 | +21.4% | 0.02% | +26.7% |
| Q3 2019 | $54,485,000 | -1.7% | 626,975 | +3.3% | 0.02% | 0.0% |
| Q2 2019 | $55,415,000 | -4.3% | 606,874 | +0.7% | 0.02% | -6.2% |
| Q1 2019 | $57,926,000 | +5.3% | 602,504 | -6.0% | 0.02% | -5.9% |
| Q4 2018 | $54,990,000 | +0.4% | 640,815 | +0.8% | 0.02% | +21.4% |
| Q3 2018 | $54,780,000 | +5.7% | 635,797 | -7.4% | 0.01% | 0.0% |
| Q2 2018 | $51,838,000 | -36.0% | 686,237 | -31.5% | 0.01% | -36.4% |
| Q1 2018 | $80,938,000 | -7.5% | 1,001,079 | -3.9% | 0.02% | -4.3% |
| Q4 2017 | $87,491,000 | -2.2% | 1,042,080 | -0.0% | 0.02% | -8.0% |
| Q3 2017 | $89,474,000 | +2.6% | 1,042,209 | -0.3% | 0.02% | 0.0% |
| Q2 2017 | $87,223,000 | +8.9% | 1,044,975 | -3.1% | 0.02% | +13.6% |
| Q1 2017 | $80,074,000 | -3.8% | 1,078,112 | -5.7% | 0.02% | -8.3% |
| Q4 2016 | $83,261,000 | -9.3% | 1,143,055 | -1.7% | 0.02% | -11.1% |
| Q3 2016 | $91,842,000 | -8.3% | 1,163,143 | -4.2% | 0.03% | -12.9% |
| Q2 2016 | $100,168,000 | +14.0% | 1,214,011 | +0.1% | 0.03% | +14.8% |
| Q1 2016 | $87,896,000 | -18.1% | 1,213,360 | -2.7% | 0.03% | -15.6% |
| Q4 2015 | $107,300,000 | -8.7% | 1,247,101 | -2.5% | 0.03% | -11.1% |
| Q3 2015 | $117,544,000 | -21.3% | 1,278,761 | -15.8% | 0.04% | -12.2% |
| Q2 2015 | $149,355,000 | -7.6% | 1,518,767 | -7.4% | 0.04% | -2.4% |
| Q1 2015 | $161,719,000 | -10.4% | 1,640,000 | -15.8% | 0.04% | -10.6% |
| Q4 2014 | $180,542,000 | +52.3% | 1,948,443 | +54.7% | 0.05% | +46.9% |
| Q3 2014 | $118,570,000 | -48.7% | 1,259,626 | -50.7% | 0.03% | +3.2% |
| Q2 2014 | $231,268,000 | +79.8% | 2,554,634 | +68.9% | 0.03% | -11.4% |
| Q1 2014 | $128,608,000 | +21.0% | 1,512,679 | +14.4% | 0.04% | +16.7% |
| Q4 2013 | $106,273,000 | -49.2% | 1,322,118 | -51.6% | 0.03% | -3.2% |
| Q3 2013 | $209,396,000 | +183.4% | 2,729,686 | +161.2% | 0.03% | +34.8% |
| Q2 2013 | $73,892,000 | – | 1,045,005 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |